Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-04-18

Clinical Trial Update: AVODART(Dutasteride) Post-marketing Surveillance(PMS)

View source ↗

Summary

A post-marketing surveillance trial for Avodart (dutasteride) completed and posted its results in 2011.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Avodart (dutasteride)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Benign Prostatic Hyperplasia, Prostatic Hyperplasia | Status: COMPLETED | Results posted: 2011-04-18